v3 Template
C

Connect Biopharma Holdings Limited

Biopharmaceutical ~260 employees
Founded
--
Employees (Est.)
~260
13 leaders known
Total Funding
$20.2M
Funding Rounds
1
Last Funding
2026-03-30

About Connect Biopharma Holdings Limited

Connect Biopharma is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and COPD, aspiring to improve patients' lives through next-generation therapeutics for inflammatory diseases.

Products & Services

Rademikibart (CBP-201):A therapeutic candidate for inflammatory diseases, with ongoing clinical studies such as a Phase 3 study for moderate-to-severe atopic dermatitis.

Specialties

Inflammatory Diseases Asthma COPD Next-Generation Therapeutics

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Private Placement
T: -
FT: Private Placement 		A: 20200000
MR: -
FA: $20.2 million
FAN: 20200000 		D: 2026-03-30
FD: 2026-03-30 		1 investors
Private Placement Latest
2026-03-30
$20.2M
1 investor (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

K

Kleanthis G. Xanthopoulos

Chairman

J

James Z. Huang

Founding Partner of Panacea Venture

J

Jean Liu

Board Director

B

Barry Quart

CHIEF EXECUTIVE OFFICER AND DIRECTOR

J

James A. Schoeneck

Board Director

K

Karen J. Wilson

Board Director

View 10 more team members with Pro

Unlock Full Team Directory

Recent News

Connect Biopharma Holdings Limited Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical
Company Size
~260 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro